Health Canada approves Exact Imaging's FusionVu
Health Canada has approved ultrasound technology developer Exact Imaging's...Read more on AuntMinnie.comRelated Reading: Exact Imaging secures urology group purchasing contract FDA OK's Exact Imaging's FusionVu Exact Imaging completes Va. install Exact Imaging launches microultrasound/MRI device Exact Imaging wins Canadian approval for ExactVu
Authors: Grisotto S, Cerrotta A, Pappalardi B, Carrara M, Messina A, Tenconi C, Valdagni R, Fallai C Abstract Purpose: The purpose of this study was to compare the prostate contours drawn by two radiation oncologists and one radiologist on magnetic resonance (MR) and transrectal ultrasound (TRUS) images. TRUS intra- and inter-fraction variability as well as TRUS vs. MR inter-modality and inter-operator variability were studied. Material and methods: Thirty patients affected by localized prostate cancer and treated with interstitial high-dose-rate (HDR) prostate brachytherapy at the National Cancer Institute in ...
Gerstner, GR, Giuliani, HK, Mota, JA, and Ryan, ED. Influence of muscle quality on the differences in strength from slow to fast velocities in career firefighters. J Strength Cond Res 32(10): 2982–2986, 2018—The purpose of this study was to examine the relationship between ultrasound-derived muscle quality and the %decrease in peak torque (PT) from slow to fast velocities in career firefighters. Thirty-nine male career firefighters (mean ± SD: age = 36.90 ± 6.87 years; stature = 180.93 ± 6.98 cm; mass = 109.30 ± 20.57 kg; and body mass index [BMI] = 33.24 ± 4.95 kg·m&mi...
Conclusion: This series reports a higher diagnostic yield than most other published studies and opens platform for direct comparison of each available needle. It also adds to the safety data for this larger needle. In addition, it raises doubt into utility of TBLB for diagnosis of sarcoidosis, which can increase the procedural complications.
Background: The 2016 CHEST consensus guidelines recommend use of either 21- or 22-G needles for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). We decided to prospectively compare sample adequacy and diagnostic yield of the 19-G with the 22-G EBUS needle, hypothesizing that a larger gauge difference might magnify the differences between 2 needle sizes. Methods: Twenty-seven patients undergoing EBUS-TBNA at our institution were evaluated. All cases were performed by a single operator formally trained in interventional pulmonology. Both Olympus 19- and 22-G needles were used at each lymph n...
Conclusion: In select cases where additional tissue may be needed, sampling with a 19-G EBUS needle following standard aspiration with a 22-G needle results in an increase in diagnostic yield.
Conclusion: CP-EBUS-guided FM placement for patients with malignant lymph nodes and central parenchymal lung lesions appears to be safe and feasible.
This study assesses the sampling utility of convex probe EBUS-visible intrapulmonary lesions not visualized by the white-light bronchoscopy. Methods: A retrospective analysis of EBUS-TBNA of EBUS-visible intrapulmonary lesions was performed between January 2010 and March 2015. Patients with visible endobronchial lesions by white-light bronchoscopy were excluded from analysis. Results: Among 108 procedures, the diagnostic yield of EBUS-TBNA for EBUS-visible intrapulmonary lesions was 87%. Following diagnoses were established: lung cancer (73/67.6%), lung metastases (10/9.2%), infection (5/4.6%), lymphoma (1/
No abstract available
Publication date: October 2018Source: Seminars in Ultrasound, CT and MRI, Volume 39, Issue 5Author(s): Humberto Morales
Conclusions: Liver biopsy is safe in the majority of patients with PALF and associated with infrequent major complications. Clinicians should consider performing liver biopsy in this setting, especially when the transjugular approach is feasible, since findings may guide diagnosis and therapy.